CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies.

Elisabetta Zanatta,Andrea Martini,Roberto Depascale, Anna Gamba,Marta Tonello,Mariele Gatto,Chiara Giraudo,Elisabetta Balestro,Andrea Doria,Luca Iaccarino

Diagnostics (Basel, Switzerland)（2023）

引用 0|浏览7

暂无评分

摘要

Although in a relatively small sample, our data suggest that CCL18 is a useful biomarker in IIMs-ILD, particularly in the early identification of patients at risk of developing PF-ILD.

查看译文

关键词

interstitial lung disease (ILD), idiopathic inflammatory myopathies (IIMs), biomarkers, autoantibodies, progressive pulmonary fibrosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要